Evolving data on cardiovascular complications in cancer
During the 11th ICTHIC, Hugo Ten Cate talked about the evolving data on cardiovascular complications in cancer. Here,...
LATEST ARTICLES
The impact of warfarin on overall survival in cancer patients with VTE
During the 11th ICTHIC, 2022, Jeffrey Zwicker talked about the impact of warfarin on overall survival (OS) in cancer...
Venus thromboembolism and risk stratification and hematological malignancies
In recent years, the incidence of venous thromboembolism (VTE) has been rising in patients with cancer. A Danish cohort...
Diagnosis, screening, and prevention of cancer-associated thrombosis
The tight association between malignancies and hypercoagulation was highlighted almost a century ago by the...
PODCAST. Drug-drug interactions: Implications for anticoagulation use in patients with cancer
Cancer patients have an increased risk of VTE by at least 12-fold, and cancer therapies increase the risk of VTE by a...
Flash Interviews from the 11th ICTHIC – Part 2
Andrés J. Munoz Martin: What are the main take-home messages from “Mortality impact of cancer-associated venous...